Literature DB >> 7722412

Pathways for the processing and presentation of antigens to T cells.

J J Monaco1.   

Abstract

Two pathways exist within vertebrate cells to generate peptides for recognition by T cells. The "endogenous" pathway provides peptides to MHC class I molecules for presentation to CD8+ T cells. These peptides are derived from proteins synthesized or residing in the cytoplasm or nucleus, and involves proteasomes and the ubiquitin pathway of protein degradation, as well as a specific peptide transporter (TAP) that allows these peptides access to the lumen of the endoplasmic reticulum. The exogenous pathway provides peptides to MHC class II molecules for presentation to CD4+ T cells. These peptides are derived from extracellular antigens taken up by endocytosis and degraded in the endosomal/lysosomal pathway. Peptide loading of MHC class II molecules requires the presence of a molecule (H-2M in mouse, HLA-DM in humans) that is structurally related to MHC class II molecules, but the mechanistic basis of this requirement is unknown. The class II region of the MHC contains a cluster of genes encoding proteins involved in antigen processing, including genes for two proteasome subunits (LMP2 and LMP7), the peptide transporter heterodimer (TAP1 and TAP2), and the H-2M/HLA-DM molecule (Ma and Mb, or DMA and DMB).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722412     DOI: 10.1002/jlb.57.4.543

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

Review 1.  Prosomes (proteasomes) changes during differentiation are related to the type of inducer.

Authors:  J P Bureau; L Henry; A Baz; K Scherrer; M T Château
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

2.  Characterization and phylogenetic analysis of a cnidarian LMP X-like cDNA.

Authors:  Larry J Dishaw; Manuel L Herrera; Charles H Bigger
Journal:  Immunogenetics       Date:  2006-03-22       Impact factor: 2.846

Review 3.  Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Authors:  Sung-Mi Kim; YongQiang Wang; Noushin Nabavi; Yi Liu; Maria Almira Correia
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

4.  Convergent synthesis of neoglycopeptides by coupling of 2-bromoethyl glycosides to cysteine and homocysteine residues in T cell stimulating peptides.

Authors:  M Bengtsson; J Broddefalk; J Dahmén; K Henriksson; J Kihlberg; H Lönn; B R Srinivasa; K Stenvall
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

5.  Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells.

Authors:  E Storozynsky; J G Woodward; J G Frelinger; E M Lord
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 6.  Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.

Authors:  A J Barrett; K Rezvani
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

7.  Us9, a stable lysine-less herpes simplex virus 1 protein, is ubiquitinated before packaging into virions and associates with proteasomes.

Authors:  R Brandimarti; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

8.  Loss of T cell responses following long-term cryopreservation.

Authors:  Rachel E Owen; Elizabeth Sinclair; Brinda Emu; John W Heitman; Dale F Hirschkorn; C Lorrie Epling; Qi Xuan Tan; Brian Custer; Jeffery M Harris; Mark A Jacobson; Joseph M McCune; Jeffery N Martin; Frederick M Hecht; Steven G Deeks; Philip J Norris
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

9.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

10.  Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.

Authors:  Yuexin Pan; Jerzy Trojan; Yajun Guo; Donald D Anthony
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.